Optimizing T-cell receptor avidity with somatic hypermutation. Bassan D, Gozlan YM, Sharbi-Yunger A, Tzehoval E, et al. Int J Cancer 2019;145:2816-2826.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bassan D, Gozlan YM, Sharbi-Yunger A, Tzehoval E, et al. Optimizing T-cell receptor avidity with somatic hypermutation. Int J Cancer 2019;145:2816-2826.
PMID: 31381134